BCLI

Brainstorm Cell Therapeutics Inc. Common Stock NASDAQ Capital Market
$3.98
Open: $3.31 High: $3.96 Low: $3.25 Close: $3.96
Range: 2021-11-25 - 2021-11-26
Volume:737,002
Market: Closed
BCLI
Brainstorm Cell Therapeutics Inc. Common Stock 1745 Broadway Hackensack NJ, 7601 http://www.brainstorm-cell.com
Brainstorm Cell Therapeutics Inc is a biotechnology company. The Company develops novel adult stem cell therapies for debilitating neurodegenerative disorders such as ALS, MS, and PD among others.
  • CEO: Chaim Lebovits
  • Employees: 31
  • Sector: Healthcare
  • Industry: Biotechnology
Latest Stocks Posts
Card image
Card image
Card image
BCLI News
Latest news about the BCLI